Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate, or extent of CD4-positive, alpha-beta T cell differentiation. [GOC:add, GOC:pr, ISBN:0781735149]
Negative regulation of CD4-positive, alpha-beta T cell differentiation is a complex process involving multiple molecular mechanisms that suppress the development of CD4+ T helper cells from precursor cells. This process is crucial for maintaining immune homeostasis and preventing autoimmune responses. Here is a detailed description:
**1. Transcriptional Regulation:**
* **Foxp3 Expression:** The transcription factor Foxp3 is a master regulator of regulatory T cell (Treg) development. Treg cells play a critical role in suppressing the differentiation of CD4+ T cells into other lineages. Expression of Foxp3 is tightly regulated by various factors, including signaling pathways like TGF-beta, IL-2, and retinoic acid.
* **ThPOK Downregulation:** ThPOK is a transcription factor essential for CD4+ T cell differentiation towards the Th1 and Th2 lineages. During Treg development, ThPOK expression is downregulated, preventing differentiation into these effector cell types.
* **Suppression of Th1/Th2 lineage-specific transcription factors:** Expression of lineage-specific transcription factors, such as T-bet (for Th1) and GATA3 (for Th2), is also suppressed during Treg differentiation, further contributing to the inhibition of effector T cell development.
**2. Signaling Pathways:**
* **TGF-beta Signaling:** TGF-beta is a key cytokine involved in Treg development. It activates the SMAD2/3 signaling pathway, leading to the expression of Foxp3 and other genes involved in Treg function. TGF-beta also inhibits the development of other CD4+ T cell lineages by suppressing IL-2 production and activation of the JAK-STAT signaling pathway.
* **IL-2 Signaling:** IL-2 is a critical cytokine for T cell growth and differentiation. In the context of Treg development, IL-2 plays a paradoxical role. While it is required for Treg survival and proliferation, it also suppresses the differentiation of CD4+ T cells into other lineages. This is mediated through the activation of STAT5, which inhibits the expression of Th1/Th2 lineage-specific transcription factors.
* **Retinoic Acid Signaling:** Retinoic acid is a metabolite of Vitamin A that plays an important role in immune regulation. It promotes the differentiation of Treg cells by inducing Foxp3 expression and suppressing the development of Th17 cells.
**3. Epigenetic Modifications:**
* **DNA Methylation:** DNA methylation patterns are crucial for regulating gene expression. During Treg development, specific regions of the Foxp3 locus become demethylated, leading to increased expression of the Foxp3 gene.
* **Histone Modifications:** Histone modifications, such as acetylation and methylation, can also influence gene expression. Treg development involves specific histone modifications that promote Foxp3 expression and suppress the expression of other lineage-specific genes.
**4. Cell-Cell Interactions:**
* **Dendritic Cell-T cell Interactions:** Dendritic cells (DCs) play a crucial role in T cell development. They can induce the differentiation of Treg cells by producing TGF-beta and other factors.
* **Treg-Effector T cell Interactions:** Treg cells can directly interact with effector T cells and suppress their activation and differentiation through various mechanisms, including the production of immunosuppressive cytokines like IL-10 and TGF-beta.
**Conclusion:**
Negative regulation of CD4-positive, alpha-beta T cell differentiation is a multi-faceted process involving intricate transcriptional, signaling, epigenetic, and cell-cell interaction mechanisms. This complex regulation is essential for maintaining immune tolerance and preventing autoimmune diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
High mobility group protein B1 | A high mobility group protein B1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P09429] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
salicylic acid | Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL). | monohydroxybenzoic acid | algal metabolite; antifungal agent; antiinfective agent; EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor; keratolytic drug; plant hormone; plant metabolite |
diflunisal | diflunisal : An organofluorine compound comprising salicylic acid having a 2,4-difluorophenyl group at the 5-position. Diflunisal: A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN. | monohydroxybenzoic acid; organofluorine compound | non-narcotic analgesic; non-steroidal anti-inflammatory drug |
glycyrrhizic acid | glycyrrhizinic acid : A triterpenoid saponin that is the glucosiduronide derivative of 3beta-hydroxy-11-oxoolean-12-en-30-oic acid. | enone; glucosiduronic acid; pentacyclic triterpenoid; tricarboxylic acid; triterpenoid saponin | EC 3.4.21.5 (thrombin) inhibitor; plant metabolite |
methotrexate | dicarboxylic acid; monocarboxylic acid amide; pteridines | abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent |